Literature DB >> 3919981

Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.

J A Brieva, J Sequi, J M Zabay, A Pardo, A Campos, M Luz de la Sen, A Bootello.   

Abstract

The present study was performed to evaluate B cell function in haemophiliacs. Spontaneous and pokeweed mitogen (PWM)-induced immunoglobulin (Ig) production was determined by ELISA in the supernatants of cultured peripheral blood lymphocytes (PBL) from 14 haemophiliacs and 17 normal donors. Spontaneous IgM, IgA and IgG production was three times higher in patients than normal controls, while PWM-induced IgM, IgA and IgG production was markedly reduced in patients compared to normal donors (P less than 0.025). Allogeneic co-cultures of haemophiliacs and normal B plus T cell fractions revealed that these results are due to a defect of the patients' T cell depleted fraction. These abnormalities were not found in three patients who had received no clotting factor concentrates for at least 1 year prior to the study. Additionally, the annual amount of clotting factor concentrates received by treated patients correlates well with the enhancement of spontaneous Ig production (r = +0.688, P less than 0.02), the decrease of PWM-induced Ig secretion (r = -0.655, P less than 0.02), and the elevation of serum IgG levels (r = +0.610, P less than 0.05). These findings suggest that the administration of clotting factor concentrates play an important role in the altered B cell function in haemophiliacs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919981      PMCID: PMC1577117     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.

Authors:  R E Enck; R F Betts; M R Brown; G Miller
Journal:  Transfusion       Date:  1979 Jan-Feb       Impact factor: 3.157

2.  Transfusion-related short-incubation hepatitis in hemophilic patients.

Authors:  M A Hruby; V Schauf
Journal:  JAMA       Date:  1978-09-22       Impact factor: 56.272

3.  Asymptomatic structural liver disease in hemophilia.

Authors:  J A Spero; J H Lewis; D H Van Theil; U Hasiba; B S Rabin
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization.

Authors:  R H Stevens; E Macy; C Morrow; A Saxon
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

6.  Evidence that pokeweed-mitogen-reactive B cells are pre-committed in vivo to the high-rate secretion of a single immunoglobulin isotype in vitro.

Authors:  R H Stevens; E Macy; C J Thiele
Journal:  Scand J Immunol       Date:  1981-11       Impact factor: 3.487

7.  Single step separation of human T and B cells using AET treated srbc rosettes.

Authors:  A Saxon; J Feldhaus; R A Robins
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

8.  Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.

Authors:  G Tosato; I Magrath; I Koski; N Dooley; M Blaese
Journal:  N Engl J Med       Date:  1979-11-22       Impact factor: 91.245

9.  Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome.

Authors:  A S Fauci; H M Moutsopoulos
Journal:  Arthritis Rheum       Date:  1981-04

10.  B cell activation by cytomegalovirus.

Authors:  L M Hutt-Fletcher; N Balachandran; M H Elkins
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Effects of factor VIII concentrates on the immune system in hemophilic patients.

Authors:  S Schulman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

2.  Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients.

Authors:  V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III).

Authors:  C R Horsburgh; K C Davis; U Hasiba; S H Weiss; J J Goedert; P Sarin; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

4.  Abnormal B cell response to T cell-independent polyclonal B cell activators in haemophilia A.

Authors:  J Kekow; H Plendl; W L Gross
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

5.  Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.

Authors:  M Blombäck; H Kjellman; S Schulman; N Egberg; B Böttiger; B Wiechel
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

6.  Defective IL-6 secretion in HIV-infected haemophilia patients.

Authors:  R Weimer; S Zipperle; V Daniel; R Zimmermann; G Opelz
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.